The Danish business’s share cost has actually nearly cut in half considering that the turn of the year. Financial institution considers it an overreaction.
发布者:BY CHRISTOPHER DUE KARLSSON,转转请注明出处:https://robotalks.cn/zealand-pharma-boss-on-headwinds-following-eli-lilly-data-petrelintide-potential-unaffected/